Onyx Healthcare Inc.

TWO:6569 Taiwan Health Information Services
Market Cap
$113.91 Million
NT$3.77 Billion TWD
Market Cap Rank
#22766 Global
#1323 in Taiwan
Share Price
NT$96.60
Change (1 day)
+1.79%
52-Week Range
NT$92.80 - NT$158.00
All Time High
NT$4219.34
About

Onyx Healthcare Inc., a professional medical IT company, engages in the design, manufacture, and trade of medical computers and peripherals for hospital/clinical IT market in Taiwan, the United States, and internationally. The company offers AI ready medical PC and tablet, medical PC and monitor for digital OR, telemedicine, medical cart computer, medical power panel PC, power bank, battery manag… Read more

Onyx Healthcare Inc. (6569) - Net Assets

Latest net assets as of December 2025: NT$1.57 Billion TWD

Based on the latest financial reports, Onyx Healthcare Inc. (6569) has net assets worth NT$1.57 Billion TWD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$2.15 Billion) and total liabilities (NT$583.59 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$1.57 Billion
% of Total Assets 72.9%
Annual Growth Rate 7.45%
5-Year Change 51.73%
10-Year Change N/A
Growth Volatility 12.58

Onyx Healthcare Inc. - Net Assets Trend (2019–2025)

This chart illustrates how Onyx Healthcare Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Onyx Healthcare Inc. (2019–2025)

The table below shows the annual net assets of Onyx Healthcare Inc. from 2019 to 2025.

Year Net Assets Change
2025-12-31 NT$1.57 Billion +1.12%
2024-12-31 NT$1.55 Billion +2.12%
2023-12-31 NT$1.52 Billion +8.54%
2022-12-31 NT$1.40 Billion +35.38%
2021-12-31 NT$1.03 Billion -1.72%
2020-12-31 NT$1.05 Billion +3.22%
2019-12-31 NT$1.02 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Onyx Healthcare Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 27.8% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings NT$199.33 Million 12.70%
Other Components NT$1.37 Billion 87.30%
Total Equity NT$1.57 Billion 100.00%

Onyx Healthcare Inc. Competitors by Market Cap

The table below lists competitors of Onyx Healthcare Inc. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Onyx Healthcare Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,544,593,000 to 1,570,097,000, a change of 25,504,000 (1.7%).
  • Net income of 112,133,000 contributed positively to equity growth.
  • Dividend payments of 154,523,000 reduced retained earnings.
  • New share issuances of 41,507,000 increased equity.
  • Other factors increased equity by 26,387,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income NT$112.13 Million +7.14%
Dividends Paid NT$154.52 Million -9.84%
Share Issuances NT$41.51 Million +2.64%
Other Changes NT$26.39 Million +1.68%
Total Change NT$- 1.65%

Book Value vs Market Value Analysis

This analysis compares Onyx Healthcare Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.40x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 2.94x to 2.40x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 NT$32.86 NT$96.60 x
2020-12-31 NT$29.41 NT$96.60 x
2021-12-31 NT$29.76 NT$96.60 x
2022-12-31 NT$36.99 NT$96.60 x
2023-12-31 NT$39.07 NT$96.60 x
2024-12-31 NT$39.99 NT$96.60 x
2025-12-31 NT$40.19 NT$96.60 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Onyx Healthcare Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.14%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 8.54%
  • • Asset Turnover: 0.61x
  • • Equity Multiplier: 1.37x
  • Recent ROE (7.14%) is below the historical average (14.65%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 23.75% 16.14% 1.08x 1.37x NT$138.58 Million
2020 16.02% 12.40% 0.97x 1.34x NT$62.78 Million
2021 12.43% 10.61% 0.71x 1.66x NT$24.96 Million
2022 14.58% 12.68% 0.81x 1.41x NT$63.78 Million
2023 16.89% 17.10% 0.73x 1.36x NT$104.10 Million
2024 11.71% 14.58% 0.59x 1.36x NT$26.45 Million
2025 7.14% 8.54% 0.61x 1.37x NT$-44.88 Million

Industry Comparison

This section compares Onyx Healthcare Inc.'s net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $914,447,000
  • Average return on equity (ROE) among peers: -1.17%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Onyx Healthcare Inc. (6569) NT$1.57 Billion 23.75% 0.37x $35.87 Million
Ever Fortune.AI Co. Ltd. (6841) $1.51 Billion -3.59% 0.03x $109.81 Million
EBM Technologies Incorporated (8409) $319.60 Million 1.25% 0.47x $11.16 Million